A prominent non-government funder of childhood research grants, the St. Baldrick’s Foundation, formalized a partnership with the Dallas, Texas, based TeamConnor Childhood Cancer Foundation. Combined they will help fund the work of Dr. Erica Braverman at Children’s Hospital of Pittsburgh, who is working on finding a way to alter tumor-targeting immune cells, which make them last longer when the cells are given back to the patients. The goal: introduce long-term cures for childhood cancer without the need for additional treatment. These organizations are on a mission to overcome childhood cancers.
Oncologists have been experimenting with new cancer therapies, like CAR-T cell therapy, that uses the patient’s immune system to fight against their cancer. Although the treatment has shown promise, there are many cases in which it does not work. Unfortunately, once cancers have resisted a specific treatment once, it is difficult to use the same treatment again. Dr. Braverman at Children’s Hospital of Pittsburgh aims to make the altered immune cells last longer. If successful, it could allow long-term cures for childhood cancer without the need for further treatment.
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).